Clinical Trials Browser

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Clinical Trials

ROWAN

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

SCR-ESCC-01

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Neoadjuvant Treatment Modalities in Esophageal Cancer

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

A Benefit Population Atlas of nICT Versus nCT for LAGC

AGAMENON

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

OMEC-5

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

ONTRESCC

C-MSI

BTCICTY-001

ICC

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

iMHRT-LARC

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

REICRAE

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

AK104-IIT-13

TREE

NACSOC-02

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Miracle-1

CRATER

RECORD

Thermal Ablation Followed by Immunotherapy for HCC

WATCHER

Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma